IK1 inhibitor PA-6 structure
|
Common Name | IK1 inhibitor PA-6 | ||
|---|---|---|---|---|
| CAS Number | 500715-03-7 | Molecular Weight | 492.61 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C31H32N4O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of IK1 inhibitor PA-6IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor, with IC50 values of 12-15 nM for human and mouse KIR2.x currents. IK1 inhibitor PA-6 (PA-6) elevates KIR2.1 protein expression and induces intracellular KIR2.1 accumulation. IK1 inhibitor PA-6 (PA-6) has the potential to treat atrial fibrillation and arrhythmia[1][2][3]. |
| Name | IK1 inhibitor PA-6 |
|---|
| Description | IK1 inhibitor PA-6 (PA-6), a pentamidine analogue, is a selective and potent IK1 (KIR2.x ion-channel-carried inward rectifier current) inhibitor, with IC50 values of 12-15 nM for human and mouse KIR2.x currents. IK1 inhibitor PA-6 (PA-6) elevates KIR2.1 protein expression and induces intracellular KIR2.1 accumulation. IK1 inhibitor PA-6 (PA-6) has the potential to treat atrial fibrillation and arrhythmia[1][2][3]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 12-15 nM (KIR2.x currents)[1]. |
| References |
| Molecular Formula | C31H32N4O2 |
|---|---|
| Molecular Weight | 492.61 |